AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
Amgen (NASDAQ: AMGN) has scheduled its first quarter 2025 financial results announcement for Thursday, May 1, 2025, after market close. The company will host a conference call with the investment community at 4:30 p.m. ET.
Key highlights:
- Leadership Participation: Robert A. Bradway, chairman and chief executive officer, along with other senior management team members will lead the discussion
- Public Access: The event will be accessible to news media, investors, and the general public
- Webcast Details: Live audio will be streamed on www.amgen.com under the Investors section
- Replay Availability: The webcast recording will remain accessible for at least 90 days after the event
Interested parties can find additional information about presentation times and webcast links on Amgen's Investor Relations Events Calendar on their website.
Amgen (NASDAQ: AMGN) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 1 maggio 2025, dopo la chiusura del mercato. L'azienda terrà una conference call con la comunità degli investitori alle 16:30 ET.
Punti salienti:
- Partecipazione della leadership: Robert A. Bradway, presidente e amministratore delegato, insieme ad altri membri del team di alta dirigenza, guiderà la discussione
- Accesso pubblico: L'evento sarà aperto a media, investitori e pubblico generale
- Dettagli della diretta web: L'audio in diretta sarà trasmesso su www.amgen.com nella sezione Investitori
- Disponibilità della registrazione: La registrazione della diretta resterà accessibile per almeno 90 giorni dopo l'evento
Gli interessati possono trovare ulteriori informazioni sugli orari delle presentazioni e i link per la diretta nel Calendario Eventi Relazioni con gli Investitori sul sito web di Amgen.
Amgen (NASDAQ: AMGN) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 1 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada con la comunidad de inversores a las 4:30 p.m. ET.
Puntos clave:
- Participación de la dirección: Robert A. Bradway, presidente y director ejecutivo, junto con otros miembros del equipo directivo senior, liderará la discusión
- Acceso público: El evento estará abierto a medios de comunicación, inversores y al público en general
- Detalles de la transmisión: El audio en vivo se transmitirá en www.amgen.com en la sección de Inversores
- Disponibilidad de la grabación: La grabación de la transmisión estará disponible por al menos 90 días después del evento
Los interesados pueden encontrar información adicional sobre los horarios de presentación y los enlaces de la transmisión en el Calendario de Eventos de Relaciones con Inversores en el sitio web de Amgen.
암젠 (NASDAQ: AMGN)은 2025년 5월 1일 목요일, 장 마감 후에 2025년 1분기 재무 실적 발표를 예정하고 있습니다. 회사는 오후 4시 30분(동부시간)에 투자자 커뮤니티와 컨퍼런스 콜을 진행할 예정입니다.
주요 내용:
- 리더십 참여: 회장 겸 최고경영자인 로버트 A. 브래드웨이와 기타 고위 경영진이 토론을 이끕니다
- 공개 접근: 이 행사는 언론, 투자자 및 일반 대중에게 공개됩니다
- 웹캐스트 세부사항: 라이브 오디오는 www.amgen.com의 투자자 섹션에서 스트리밍됩니다
- 재방송 제공: 웹캐스트 녹화는 행사 후 최소 90일간 이용 가능합니다
관심 있는 분들은 Amgen 웹사이트의 투자자 관계 이벤트 캘린더에서 발표 시간 및 웹캐스트 링크에 관한 추가 정보를 확인할 수 있습니다.
Amgen (NASDAQ : AMGN) a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le jeudi 1er mai 2025, après la clôture du marché. La société organisera une conférence téléphonique avec la communauté des investisseurs à 16h30 ET.
Points clés :
- Participation de la direction : Robert A. Bradway, président et directeur général, ainsi que d'autres membres de la haute direction, animeront la discussion
- Accès public : L'événement sera accessible aux médias, aux investisseurs et au grand public
- Détails du webcast : L'audio en direct sera diffusé sur www.amgen.com dans la section Investisseurs
- Disponibilité du replay : L'enregistrement du webcast restera accessible pendant au moins 90 jours après l'événement
Les personnes intéressées peuvent trouver des informations supplémentaires sur les horaires des présentations et les liens du webcast dans le calendrier des événements des relations investisseurs sur le site d'Amgen.
Amgen (NASDAQ: AMGN) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 1. Mai 2025, nach Börsenschluss geplant. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz mit der Investment-Community abhalten.
Wichtige Punkte:
- Teilnahme der Führungsebene: Robert A. Bradway, Vorsitzender und CEO, sowie weitere Mitglieder des Senior-Managements werden die Diskussion leiten
- Öffentlicher Zugang: Die Veranstaltung ist für Medien, Investoren und die Öffentlichkeit zugänglich
- Webcast-Details: Der Live-Audio-Stream wird auf www.amgen.com im Bereich Investoren verfügbar sein
- Wiedergabe verfügbar: Die Aufzeichnung des Webcasts wird mindestens 90 Tage nach der Veranstaltung abrufbar sein
Interessierte finden weitere Informationen zu Präsentationszeiten und Webcast-Links im Investor Relations Event-Kalender auf der Website von Amgen.
- Senior management team including CEO Robert A. Bradway will participate in the earnings call, showing high-level engagement with investors
- Extended 90-day webcast archive availability ensures transparency and accessibility for investors
- None.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, TikTok, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-first-quarter-financial-results-302439826.html
SOURCE Amgen